The fully automated kit detects human antibodies of immunoglobulin class IgG to help identify individuals with an adaptive immune response.

Paige, a specialist in computational pathology, has announced it has received FDA 510(k) clearance for the FullFocus™ viewer for primary diagnosis of digital pathology slides.

HORIBA UK Ltd, Medical has launched a digital tool for online skill evaluation and training in cytology.

Paige will use this new capital to further accelerate its mission in transforming pathology workflows in the field of cancer, while working closely with biopharma companies to create custom diagnostic and clinical trial solutions to improve patient care.

EKF Diagnostics has announced that it has added a novel viral transport media for the safe sample handling and testing of multiple infectious diseases from a single swab to its product range.

Centogene and the OESIS Network have announced a partnership for COVID-19 screening of schools. The partnership will offer RT-PCR testing that can aid schools in their return to campus in the fall and continued screening to prevent a resurgence of COVID-19 over the course of the academic school year.

osteolabs GmbH has announced further validation and clinical evidence for the use of OsteoTest for the early detection of bone loss.

Freyr has announced the launch of a web platform for COVID-19 driven with real-time information for manufacturers to help them get to market and support them in emergency use authorizations with global regulatory authorities.

A new CE-IVD marked diagnostic test for microsatellite instability in solid tumors, the OncoMate™ MSI Dx Analysis System by Promega, offers UK clinicians a new option for testing for Lynch Syndrome.

Luminex Corporation has announced that the company has submitted an Emergency Use Authorization request to the U.S. Food and Drug Administration (FDA) for its xMAP® SARS-CoV-2 Multi-Antigen IgG assay.